Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
Product: Eloxatin
Active Ingredient: Oxaliplatin 100mg
Dosage Form: Powder for infusion
New Zealand Sponsor: Sanofi-Synthelabo (NZ) Limited
Manufacturer: Laboratoires Thissen SA, Braine-L'Alleud, Belgium
Product: Eloxatin
Active Ingredient: Oxaliplatin 50mg
Dosage Form: Powder for injection
New Zealand Sponsor: Sanofi-Synthelabo (NZ) Limited
Manufacturer: Laboratoires Thissen SA, Braine-L'Alleud, Belgium
Dated this 2nd day of February 2004.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on the
6th day of July 2001).